BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Authors » Douglas Merrill

Articles by Douglas Merrill

Germany Issues Regulations Concerning New Stem Cell Law

July 17, 2002
By Douglas Merrill

Germany Issues Regulations Concerning New Stem Cell Law

July 17, 2002
By Douglas Merrill

Biopsytec Raises EUR5M In Second Round Of Financing

July 10, 2002
By Douglas Merrill

Biopsytec Raises EUR5M In Second Round Of Financing

July 10, 2002
By Douglas Merrill

Paion Wins EUR4.9 Million Grant From German State Government

July 3, 2002
By Douglas Merrill

Paion Wins EUR4.9 Million Grant From German State Government

July 3, 2002
By Douglas Merrill

Modex Completes Phase I Allox Trial, Eyes Industry Consolidation

June 26, 2002
By Douglas Merrill

Modex Completes Phase I Allox Trial, Eyes Industry Consolidation

June 26, 2002
By Douglas Merrill

Merck Chief Considers Building In U.S. Rather Than Germany

June 19, 2002
By Douglas Merrill

German BioChance Program Funds Six Start-Up Companies

June 19, 2002
By Douglas Merrill
MUNICH, Germany - The German Ministry of Education and Research is supporting six new biotech companies with grants of approximately €1 million (US$950,000) each. The investment is part of the BioChance program, which has delivered more than €50 million to 52 biotech start-ups since the program's start in 1999. (BioWorld International)
Read More
Previous 1 2 … 19 20 21 22 23 24 25 26 27 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing